Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis
NCT01473797Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2011
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cladribine in pulmonary Langerhans cell histiocytosis (PLCH), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
cladribine
03
Conditions
pulmonary Langerhans cell histiocytosis (PLCH)
Beyond the preview
Go deeper on NCT01473797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473797.